???global.info.a_carregar???
Pedro Miguel Teixeira Brites graduated in Biology at the Faculty of Sciences, University of Porto, and obtained his Ph.D. in Medicine at the Faculty of Medicine, University of Amsterdam. His research as a Ph.D. student contributed to identifying the gene associated with the peroxisomal disorder Rhizomelic Chondrodysplasia Punctata (RCDP; published in Nature Genetics) and elucidating the molecular basis of this disease (two publications in the American Journal of Human Genetics). This work highlighted plasmalogens' role, a class of ether-phospholipids, as key cellular constituents whose deficiency dictates the disease state and presentation. P.Brites subsequently characterized mouse models of two peroxisomal disorders to further understand the consequences of impaired peroxisomal functioning (published in Human Molecular Genetics and the Proceedings of the National Academy of Sciences, USA). The importance of these mouse models was highlighted by the identification that a deficiency in plasmalogens modulates nervous tissue pathology (published in Brain). In 2009, P. Brites joined the Nerve Regeneration group at Instituto de Biologia Molecular e Celular - IBMC, Porto, and initiated independent research focused on understanding plasmalogens' role in nervous tissue and dissecting the cellular mechanisms governed by these phospholipids. Recent work unraveled that ether-phospholipids regulate AKT activation to mediate Schwann cell development and myelination (published in Journal Clinical Investigation) and protect myelin from oxidative damage (published in Free Radical Biology and Medicine). The translational efforts led to the first proposal of a replacement therapy for plasmalogen defects (published in Plos One) and discovering alternative agents capable of bypassing the need for plasmalogens (published in Journal Clinical Investigation and Brain Pathology). P.Brites supervised 9 undergraduate students, 5 MSc students, 5 researcher technicians, 2 Ph.D. students, and 3 post-docs. Since 2017, P.Brites is the group leader of the Neurolipid biology group at IBMC and i3S that aims at understanding how (phospho) lipids govern fundamental cellular processes, how a lipid dysregulation of these processes mediates the pathophysiology, and use the knowledge gathered to develop effective therapeutic strategies. P.Brites serves as Scientific Coordinator of the Histology and Electron Microscopy Sciences platform at i3S, and of the unit for the generation of mutant mice using CRISPR-cas9 technology within the Animal Facility at i3S.
Identificação

Identificação pessoal

Nome completo
Pedro Miguel Teixeira Brites

Nomes de citação

  • Brites, Pedro

Identificadores de autor

Ciência ID
5B1D-915A-2994
ORCID iD
0000-0003-1754-1543
Researcher Id
K-4231-2013

Endereços de correio eletrónico

  • pedro.brites@ibmc.up.pt (Profissional)

Moradas

  • Instituto de Investigação e Inovação em Saúde - i3S. Neurolipid Biology group - Rua Alfredo Allen 208, 4200-135, Porto, Porto, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde
  • Ciências Médicas e da Saúde - Medicina Básica - Neurociências

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Holandês Utilizador elementar (A1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador elementar (A1)
Francês Utilizador elementar (A1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2009
Concluído
Medicine (Doutoramento)
Universiteit van Amsterdam, Países Baixos
"The mouse as a model to understand peroxisomal disorders" (TESE/DISSERTAÇÃO)
N.A.
1998
Frequentou
Biologia (Licenciatura)
Universidade do Porto Faculdade de Ciências, Portugal
"Molecular and biochemical studies in human peroxisomal disorders" (TESE/DISSERTAÇÃO)
12
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento
Empregador
2020/07/01 - Atual Investigador principal (carreira) (Investigação) Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2019/01/01 - 2020/06/30 Investigador principal (carreira) (Investigação) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2013/06/26 - 2018/06/30 Investigador Auxiliar (carreira) (Investigação) Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2009/02/01 - 2013/06/24 Pós-doutorado (Investigação) Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2001/02/01 - 2008/11/30 Investigador (Investigação) Academisch Medisch Centrum Faculteit Geneeskunde, Países Baixos

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento
Empregador
2009/02/01 - Atual Leitor (Docente Universitário) Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento
Empregador
2020/07/01 - Atual Principal researcher appointment under the FCT CEEC ind - ceecind/02086 Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2018/01/02 - Atual Scientific coordinator of the production of genetically modified mice at i3S animal facility Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2017/01/10 - Atual Scientific coordinator of the Histology and Electron Microscopy facility Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2017/01/01 - Atual Group Leader of the Neurolipid Biology Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2013/06/15 - 2018/06/14 Assistant researcher position under FCT Investigator . IF/00107/2012 Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Outros

Categoria Profissional
Instituição de acolhimento
Empregador
1996/10/16 - 2000/11/30 Pre-doctoral fellow under the supervion of Prof. Dr. Henk F. Tabak Academisch Medisch Centrum Faculteit Geneeskunde, Países Baixos
1995/09/15 - 1996/09/30 Graduate student Instituto Gulbenkian de Ciência, Portugal
1993/06/14 - 1995/08/31 Research Intern Centro de Genética Médica Doutor Jacinto Magalhães, Portugal
Projetos

Projeto

Designação Financiadores
2022/04/01 - Atual Unravelling the pathology and disease mechanisms of the newly identified leukoencephalopathy caused by impaired choline transport
ELA 2021-004I3
Investigador responsável
Association Européenne contre les Leucodystrophies, França
Em curso
2018/07/01 - Atual "Unraveling the neuropathology caused by plasmalogen deficiency: consequences, mechanism and treatment"
PTDC/MED-PAT/30558/2017 €239882
Investigador responsável
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2021/01/01 - 2025/12/31 Institute for Research and Innovation in Health
LA/P/0070/2020
Instituto Nacional de Engenharia Biomédica, Portugal

Universidade do Porto, Portugal

Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2018/07/01 - 2021/06/30 Determinação da neuropatologia por detrás de uma deficiência em plasmalogénios: consequências, mecanismos e terapia.
PTDC/MED-PAT/30558/2017
Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2019/01/01 - 2019/12/31 Instituto de Investigação e Inovação em Saúde
UID/BIM/04293/2019
Instituto Nacional de Engenharia Biomédica, Portugal

Universidade do Porto, Portugal

Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2016/04/01 - 2019/12/31 Porto Neurosciences and Neurologic Disease Research Initiative at i3S (PortoNeuroDRIve@i3S)
NORTE-01-0145-FEDER- 000008 €80000
Investigador responsável
Fundação para a Ciência e a Tecnologia

Comissao de Coordenacao e Desenvolvimento Regional do Norte
2017/04/01 - 2019/09/30 "Understanding how membrane etherphospholipids regulate neuron development and function to mediate neuropathophysiology of RCDP"
AFM/21018 €114760
Investigador responsável
The French Muscular Dystrophy Association (AFM)
Concluído
2016/02/01 - 2019/04/01 Translating Peroxisome Biogenesis Disorders: Identifying Pharmacological Therapies and Clinical Trial Endpoints
ERA-NET-E-Rare3/0001/2015 €124968
Investigador responsável
Fundação para a Ciência e a Tecnologia
Em curso
2016/02/01 - 2019/03/31 Identificação de terapias farmacológicas para doenças da biogénese dos peroxissomas.
E-Rare3/0001/2015
Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2016/01/01 - 2018/12/31 COMBINE - combinatorial regenerative strategy to potentiate axon regeneration and improve functional recovery after spinal cord injury
MC-1068-2015
Team member
Instituto Nacional de Engenharia Biomédica, Portugal
Santa Casa da Misericórdia de Lisboa
Concluído
2015/02/01 - 2016/01/31 Establishing the role and function of plasmalogens in neurons and neuron-muscle synapses¿
AFM/18815 €50000
Investigador responsável
The French Muscular Dystrophy Association (AFM)
2011/04/01 - 2014/03/31 "Developing, characterizing and rescuing animal models of leukodystrophies: role of plasmalogen in mitigating oxidative stress"
ELA/042c5 €328192
Investigador responsável
Association Européenne contre les Leucodystrophies
Concluído
2011/01/01 - 2013/12/31 "Consequences and mechanisms behind plasmalogen deficiency"
PTDC/SAUORG/ 112406/2009 €165000
Investigador responsável
Fundação para a Ciência e a Tecnologia
Concluído
2008/12/01 - 2010/11/30 "Roles of plasmalogen in myelin structure and stability, and in preventing oxidative damage"
ELA/009c4 €207416
Investigador responsável
Association Européenne contre les Leucodystrophies
Concluído
Produções

Publicações

Artigo em conferência
  1. Rodrigues, I.V.; Ferreira, P.M.; Malheiro, A.R.; Brites, P.; Pereira, E.M.; Oliveira, H.P.. "Morphometric analysis of sciatic nerve images: A directional gradient approach". 2014.
    10.1109/BIBM.2014.6999165
Artigo em revista
  1. Granadeiro, Luis; Zarralanga, Violeta Enríquez; Rosa, Ricardo; Franquinho, Filipa; Lamas, Sofia; Brites, Pedro. "Ataxia with giant axonopathy in Acbd5-deficient mice halted by adeno-associated virus gene therapy". Brain 147 4 (2024): 1457-1473. http://dx.doi.org/10.1093/brain/awad407.
    Publicado • 10.1093/brain/awad407
  2. Braz, Sandra O.; Morgado, Marlene M.; Pereira, Marta I.; Ana C. Monteiro; Golonzhka, Olga; Jarpe, Matthew; Brites, Pedro; Sousa, Monica M.; Nogueira-Rodrigues, Joana. "HDAC-6 inhibition ameliorates the early neuropathology in a mouse model of Krabbe disease". Frontiers in Molecular Neuroscience 16 (2023): http://dx.doi.org/10.3389/fnmol.2023.1231659.
    10.3389/fnmol.2023.1231659
  3. Pedro Brites; Sousa MM. "Neurons contribute to pathology in a mouse model of Krabbe disease in a cell-autonomous manner". PLOS Biology 20 7 (2022): e3001706-e3001706. http://dx.doi.org/10.1371/journal.pbio.3001706.
    10.1371/journal.pbio.3001706
  4. Qi, C.; Feng, I.; Costa, A.R.; Pinto-Costa, R.; Neil, J.E.; Caluseriu, O.; Li, D.; et al. "Variants in ADD1 cause intellectual disability, corpus callosum dysgenesis, and ventriculomegaly in humans". Genetics in Medicine 24 2 (2022): 319-331. http://www.scopus.com/inward/record.url?eid=2-s2.0-85123344009&partnerID=MN8TOARS.
    10.1016/j.gim.2021.09.014
  5. Tiago Ferreira da Silva; Luís S. Granadeiro; Diogo Bessa-Neto; Liliana L. Luz; Boris V. Safronov; Pedro Brites. "Plasmalogens regulate the AKT-ULK1 signaling pathway to control the position of the axon initial segment". Progress in Neurobiology 205 (2021): 102123-102123. https://doi.org/10.1016/j.pneurobio.2021.102123.
    10.1016/j.pneurobio.2021.102123
  6. Qi, C; Feng, I.; Costa, A.R.; Pinto-Costa, R.; Neil, J.E.; Caluseriu, O.; Ganetzky, R.D.; et al. Autor correspondente: Sousa, M.M.. "Variants in ADD1 Cause Intellectual Disability, Corpus Callosum Dysgenesis, and Ventriculomegaly in Humans". Genetics in Medicine (2021): Qi, Cai and Feng, Irena and Costa, Ana Rita and Pinto-Costa, Rita and Neil, Jennifer and Caluseriu, Oana and Bupp, Caleb and Brasch Andersen, Charlotte and Fagerberg, Christina and Ruan, Xiangbin and Kang, Bowei and Hu, Kaining and Zhong, Rong and Brites.
    No prelo
  7. Pinto-Costa, Rita; Castro Sousa, Sara; Leite, Sérgio C.; Nogueira-Rodrigues, Joana; Ferreira da Silva, Tiago; Machado, Diana; Marques, Joana Beatriz Moreira; et al. "Profilin1 delivery tunes cytoskeleton dynamics towards CNS axon regeneration". Journal of Clinical Investigation 130 4 (2020): 2024-2040. http://dx.doi.org/10.1172/jci125771.
    Publicado • 10.1172/jci125771
  8. Malheiro, Ana R.; Correia, Barbara; Ferreira da Silva, Tiago; Bessa-Neto, Diogo; Van Veldhoven, Paul P.; Brites, Pedro. "Leukodystrophy caused by plasmalogen deficiency rescued by glyceryl 1-myristyl ether treatment". Brain Pathology 29 5 (2019): 622-639. http://dx.doi.org/10.1111/bpa.12710.
    Publicado • 10.1111/bpa.12710
  9. De Munter, Stephanie; Bamps, Dorien; Malheiro, Ana Rita; Kumar Baboota, Ritesh; Brites, Pedro; Baes, Myriam. "Autonomous Purkinje cell axonal dystrophy causes ataxia in peroxisomal multifunctional protein-2 deficiency". Brain Pathology 28 5 (2018): 631-643. http://dx.doi.org/10.1111/bpa.12586.
    10.1111/bpa.12586
  10. Shinde, A.B.; Baboota, R.K.; Denis, S.; Loizides-Mangold, U.; Peeters, A.; Espeel, M.; Malheiro, A.R.; et al. "Mitochondrial disruption in peroxisome deficient cells is hepatocyte selective but is not mediated by common hepatic peroxisomal metabolites". Mitochondrion (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85029209217&partnerID=MN8TOARS.
    10.1016/j.mito.2017.08.013
  11. Franquinho, F.; Nogueira-Rodrigues, J.; Duarte, J.M.; Esteves, S.S.; Carter-Su, C.; Monaco, A.P.; Molnár, Z.; et al. "The Dyslexia-susceptibility Protein KIAA0319 Inhibits Axon Growth Through Smad2 Signaling". Cerebral cortex (New York, N.Y. : 1991) 27 3 (2017): 1732-1747. http://www.scopus.com/inward/record.url?eid=2-s2.0-85021858395&partnerID=MN8TOARS.
    10.1093/cercor/bhx023
  12. Mar, F.M.; da Silva, T.F.; Morgado, M.M.; Rodrigues, L.G.; Rodrigues, D.; Pereira, M.I.L.; Marques, A.; et al. "Myelin Lipids Inhibit Axon Regeneration Following Spinal Cord Injury: a Novel Perspective for Therapy". Molecular Neurobiology 53 2 (2016): 1052-1064. http://www.scopus.com/inward/record.url?eid=2-s2.0-84958225895&partnerID=MN8TOARS.
    10.1007/s12035-014-9072-3
  13. De Munter, S.; Verheijden, S.; Vanderstuyft, E.; Malheiro, A.R.; Brites, P.; Gall, D.; Schiffmann, S.N.; Baes, M.. "Early-onset Purkinje cell dysfunction underlies cerebellar ataxia in peroxisomal multifunctional protein-2 deficiency". Neurobiology of Disease 94 (2016): 157-168. http://www.scopus.com/inward/record.url?eid=2-s2.0-84976872223&partnerID=MN8TOARS.
    10.1016/j.nbd.2016.06.012
  14. Nogueira-Rodrigues, J.; Brites, P.; Sousa, M.M.. "Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target". Journal of Neuroscience Research 94 11 (2016): 1037-1041. http://www.scopus.com/inward/record.url?eid=2-s2.0-84990185948&partnerID=MN8TOARS.
    10.1002/jnr.23771
  15. Leite, S.C.; Sampaio, P.; Sousa, V.F.; Nogueira-Rodrigues, J.; Pinto-Costa, R.; Peters, L.L.; Brites, P.; Sousa, M.M.. "The Actin-Binding Protein a-Adducin Is Required for Maintaining Axon Diameter". Cell Reports 15 3 (2016): 490-498. http://www.scopus.com/inward/record.url?eid=2-s2.0-84962762309&partnerID=MN8TOARS.
    10.1016/j.celrep.2016.03.047
  16. Luoma, A.M.; Kuo, F.; Cakici, O.; Crowther, M.N.; Denninger, A.R.; Avila, R.L.; Brites, P.; Kirschner, D.A.. "Plasmalogen phospholipids protect internodal myelin from oxidative damage". Free Radical Biology and Medicine 84 (2015): 296-310. http://www.scopus.com/inward/record.url?eid=2-s2.0-84929162848&partnerID=MN8TOARS.
    10.1016/j.freeradbiomed.2015.03.012
  17. Rocha, D.N.; Brites, P.; Fonseca, C.; Pêgo, A.P.. "Poly(trimethylene carbonate-co-e-caprolactone) promotes axonal growth". PLoS ONE 9 2 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84896121626&partnerID=MN8TOARS.
    10.1371/journal.pone.0088593
  18. Teixeira, C.A.; Miranda, C.O.; Sousa, V.F.; Santos, T.E.; Malheiro, A.R.; Solomon, M.; Maegawa, G.H.; Brites, P.; Sousa, M.M.. "Early axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe's disease". Neurobiology of Disease 66 (2014): 92-103. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896968554&partnerID=MN8TOARS.
    10.1016/j.nbd.2014.02.012
  19. Rodrigues, T.A.; Alencastre, I.S.; Francisco, T.; Brites, P.; Fransen, M.; Grou, C.P.; Azevedo, J.E.. "A PEX7-centered perspective on the peroxisomal targeting signal type 2-mediated protein import pathway". Molecular and Cellular Biology 34 15 (2014): 2917-2928. http://www.scopus.com/inward/record.url?eid=2-s2.0-84904312911&partnerID=MN8TOARS.
    10.1128/MCB.01727-13
  20. Malheiro, A.R.; da Silva, T.F.; Brites, P.. "Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome". Journal of Inherited Metabolic Disease 38 1 (2014): 111-121. http://www.scopus.com/inward/record.url?eid=2-s2.0-84922105118&partnerID=MN8TOARS.
    10.1007/s10545-014-9795-3
  21. Da Silva, T.F.; Eira, J.; Lopes, A.T.; Malheiro, A.R.; Sousa, V.; Luoma, A.; Avila, R.L.; et al. "Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination". Journal of Clinical Investigation 124 6 (2014): 2560-2570. http://www.scopus.com/inward/record.url?eid=2-s2.0-84902172153&partnerID=MN8TOARS.
    10.1172/JCI72063
  22. Miranda, C.O.; Brites, P.; Sousa, M.M.; Teixeira, C.A.. "Advances and pitfalls of cell therapy in metabolic leukodystrophies". Cell Transplantation 22 2 (2013): 189-204. http://www.scopus.com/inward/record.url?eid=2-s2.0-84874371497&partnerID=MN8TOARS.
    10.3727/096368912X656117
  23. Wiese, S.; Gronemeyer, T.; Brites, P.; Ofman, R.; Bunse, C.; Renz, C.; Meyer, H.E.; Wanders, R.J.A.; Warscheid, B.. "Comparative profiling of the peroxisomal proteome of wildtype and Pex7 knockout mice by quantitative mass spectrometry". International Journal of Mass Spectrometry 312 (2012): 30-40. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857056323&partnerID=MN8TOARS.
    10.1016/j.ijms.2011.09.005
  24. Da Silva, T.F.; Sousa, V.F.; Malheiro, A.R.; Brites, P.. "The importance of ether-phospholipids: A view from the perspective of mouse models". Biochimica et Biophysica Acta - Molecular Basis of Disease 1822 9 (2012): 1501-1508. http://www.scopus.com/inward/record.url?eid=2-s2.0-84864039497&partnerID=MN8TOARS.
    10.1016/j.bbadis.2012.05.014
  25. Brites, P.; Ferreira, A.S.; da Silva, T.F.; Sousa, V.F.; Malheiro, A.R.; Duran, M.; Waterham, H.R.; Baes, M.; Wanders, R.J.A.. "Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice". PLoS ONE 6 12 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-82755170548&partnerID=MN8TOARS.
    10.1371/journal.pone.0028539
  26. Wanders, R.J.; Brites, P.. "Biosynthesis of ether-phospholipids including plasmalogens, peroxisomes and human disease: New insights into an old problem". Clinical Lipidology 5 3 (2010): 379-386. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953817755&partnerID=MN8TOARS.
    10.2217/clp.10.16
  27. Wanders, R.J.A.; Ferdinandusse, S.; Brites, P.; Kemp, S.. "Peroxisomes, lipid metabolism and lipotoxicity". Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1801 3 (2010): 272-280. http://www.scopus.com/inward/record.url?eid=2-s2.0-76349092667&partnerID=MN8TOARS.
    10.1016/j.bbalip.2010.01.001
  28. Brites, P.; Mooyer, P.A.W.; El Mrabet, L.; Waterham, H.R.; Wanders, R.J.A.. "Plasmalogens participate in very-long-chain fatty acid-induced pathology". Brain 132 2 (2009): 482-492. http://www.scopus.com/inward/record.url?eid=2-s2.0-60149094802&partnerID=MN8TOARS.
    10.1093/brain/awn295
  29. Cuperus R; Tytgat GA; Leen R; Brites P; Bras J; Caron HN; Van Kuilenburg AB. "Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids.". (2008): http://europepmc.org/abstract/med/18425327.
  30. Ferdinandusse, S.; Zomer, A.W.M.; Komen, J.C.; Van Den Brink, C.E.; Thanos, M.; Hamers, F.P.T.; Wanders, R.J.A.; et al. "Ataxia with loss of Purkinje cells in a mouse model for Refsum disease". Proceedings of the National Academy of Sciences of the United States of America 105 46 (2008): 17712-17717. http://www.scopus.com/inward/record.url?eid=2-s2.0-56649124783&partnerID=MN8TOARS.
    10.1073/pnas.0806066105
  31. Willemsen, A.M.; Jansen, G.A.; Komen, J.C.; van Hooff, S.; Waterham, H.R.; Brites, P.M.T.; Wanders, R.J.A.; van Kampen, A.H.C.. "Organization and integration of biomedical knowledge with concept maps for key peroxisomal pathways". Bioinformatics 24 16 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-49549117583&partnerID=MN8TOARS.
    10.1093/bioinformatics/btn274
  32. Cuperus, R.; Tytgat, G.A.M.; Leen, R.; Brites, P.; Bras, J.; Caron, H.N.; Van Kuilenburg, A.B.P.. "Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids". International Journal of Oncology 32 5 (2008): 1011-1019. http://www.scopus.com/inward/record.url?eid=2-s2.0-45849090770&partnerID=MN8TOARS.
  33. Brites, P.; Wanders, R.J.A.; Waterham, H.R.. "The mouse as a model to understand peroxisomal biogenesis and its disorders". Drug Discovery Today: Disease Models 1 3 (2004): 193-198. http://www.scopus.com/inward/record.url?eid=2-s2.0-23644444134&partnerID=MN8TOARS.
    10.1016/j.ddmod.2004.09.003
  34. Brites, P.; Waterham, H.R.; Wanders, R.J.A.. "Functions and biosynthesis of plasmalogens in health and disease". Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1636 2-3 (2004): 219-231. http://www.scopus.com/inward/record.url?eid=2-s2.0-2942633430&partnerID=MN8TOARS.
    10.1016/j.bbalip.2003.12.010
  35. Brites, P.; Motley, A.M.; Gressens, P.; Mooyer, P.A.W.; Ploegaert, I.; Everts, V.; Evrard, P.; et al. "Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: A model for rhizomelic chondrodysplasia punctata". Human Molecular Genetics 12 18 (2003): 2255-2267. http://www.scopus.com/inward/record.url?eid=2-s2.0-10744225661&partnerID=MN8TOARS.
    10.1093/hmg/ddg236
  36. Van Den Brink, D.M.; Brites, P.; Haasjes, J.; Wierzbicki, A.S.; Mitchell, J.; Lambert-Hamill, M.; De Belleroche, J.; et al. "Identification of PEX7 as the second gene involved in Refsum disease". American Journal of Human Genetics 72 2 (2003): 471-477. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037318856&partnerID=MN8TOARS.
    10.1086/346093
  37. Motley, A.M.; Brites, P.; Gerez, L.; Hogenhout, E.; Haasjes, J.; Benne, R.; Tabak, H.F.; Wanders, R.J.A.; Waterham, H.R.. "Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1". American Journal of Human Genetics 70 3 (2002): 612-624. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036178209&partnerID=MN8TOARS.
    10.1086/338998
  38. Brites, P.; Motley, A.; Hogenhout, E.; Hettema, E.; Wijburg, F.; Heijmans, H.S.A.; Tabak, H.F.; Distel, B.; Wanders, R.J.A.. "Molecular basis of rhizomelic chondrodysplasia punctata type I: High frequency of the Leu-292 Stop mutation in 38 patients". Journal of Inherited Metabolic Disease 21 3 (1998): 306-308. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031902698&partnerID=MN8TOARS.
    10.1023/A:1005301112923
  39. Motley, A.M.; Hettema, E.H.; Hogenhout, E.M.; Brites, P.; Ten Asbroek, A.L.M.A.; Wijburg, F.A.; Baas, F.; et al. "Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor". Nature Genetics 15 4 (1997): 377-380. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031003680&partnerID=MN8TOARS.
    10.1038/ng0497-377
Livro
  1. Van Den Brink, D.M.; Brites, P.; Haasjes, J.; Wierzbicki, A.S.; Mitchell, J.; Lambert-Hamill, M.; De Belleroche, J.; et al. Identification of PEX7 as the second gene involved in Refsum disease. Springer. 2003.
  2. Jorge, P.; Brites, P.; Nogueira, A.; Aubourg, P.. Mutational analysis of an X-linked adrenoleukodystrophy (ALD) patient with detectable ALD protein. 1996.
    10.1111/j.1749-6632.1996.tb18692.x
Poster em conferência
  1. Correia, Bárbara; Zortéa, Jaqueline ; Brites, Pedro. "Synaptic transmission is affected by the lack of plasmalogens". Trabalho apresentado em Synaptic Transmission Gordon Research Conference, 2022.
  2. Correia, Bárbara; Brites, Pedro. "Plasmalogens and their role in synaptogenesis and synaptic transmission". Trabalho apresentado em 14th Göttingen Virtual Meeting of the German Neuroscience Society, 2021.
  3. Correia, Bárbara; Malheiro, Ana R.; Ferreira da Silva, Tiago; Bessa-Neto, Diogo; Van Veldhoven, Paul P.; Brites, Pedro. "Ether-phospholipids are required for oligodendrocyte maturation and their intrinsic capacity to assemble myelin". Trabalho apresentado em XIV European Meeting on Glial Cells in Health and Disease, 2019.
  4. Malheiro, Ana R.; Ferreira da Silva, Tiago; Correia, Bárbara; Brites, Pedro. "Plasmalogens regulate oligodendrocyte maturation and myelination". Trabalho apresentado em XIII European Meeting on Glial Cells in Health and Disease, 2017.
  5. Malheiro, Ana R.; Ferreira da Silva, Tiago; Correia, Bárbara; Brites, Pedro. "The (ether) link between phospholipids and myelination in the CNS". Trabalho apresentado em 4th symposium on Current Topics in Myelin Research, 2017.
Resumo em conferência
  1. Sousa, Sara Castro; Aroso, Miguel; 5E1D-7E42-BBAD; Veríssimo, Eduardo; Brites, Pedro; Aguiar, Paulo; Sousa, Monica M; Lopes, CDF. "Tension-driven axon elongation triggers cytoskeleton and membrane remodelling". Trabalho apresentado em IUBMB-EMBO Focused Meeting On Emerging Concepts Of The Neuronal Cytoskeleton (6th Edition), Santa Cruz, 2023.
  2. Rodrigues, Inês V.; Ferreira, Pedro M.; Malheiro, Ana R.; Brites, Pedro; Pereira, Eduardo Marques; Oliveira, Hélder P.. "A Directional Gradient for Morphometry of Sciatic Nerve Images". Trabalho apresentado em 6th Workshop on Biomedical Engineering, Lisboa, 2014.
    Publicado
Tese / Dissertação
  1. Brites, Pedro. "The mouse as a model to understand peroxisomal disorders". Doutoramento, 2009. http://hdl.handle.net/11245/1.323178.

Outros

Outra produção
  1. Variants in ADD1 Cause Intellectual Disability, Corpus Callosum Dysgenesis, and Ventriculomegaly in Humans. 2021. Qi, C.; Feng, I.; Costa, A.R.; Pinto-Costa, R.; Neil, J.E.; Caluseriu, O.; Bupp, C.; et al. http://www.scopus.com/inward/record.url?eid=2-s2.0-85117069952&partnerID=MN8TOARS.
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2018/06/01 Mouse models for rhizomelic chondrodysplasia punctata GFPD Scientific Conference
The Global Foundation for Peroxisomal Disorders (Washington, Estados Unidos)
2018/02/16 Phospholipid matters in the regulation of neuron and glial function Center for Neuroscience and Cell Biology (CNC) Seminar Program
University of Coimbra - Center for Neuroscience and Cell Biology (Coimbra, Portugal)
2017/09/05 Etherphospholipids and inborn errors of metabolism 13th International congress of Inborn Errors of Metabolism
Society for the Study of Inborn Errors of Metabolism - SSIEM (Rio de Janeiro, Brasil)
2017/07/13 Plasmalogen replacement therapies The development of Targeted therapies for peroxisome biogenesis disorders
The Global Foundation for Peroxisomal Disorders (Washington, Estados Unidos)
2014/02/07 The role of plasmalogens in the nervous system Workshop on “Peroxisomes and Mitochondria: Players in Cellular Metabolism
Portuguese Biochemistry Scociety (Portugal)
2013/06/14 Plasmalogens, ether-phospholipids and fatty alcohol synthesis Workshop on “Diagnostic approach, and classification of IEM affecting the synthesis and catabolism of complex lipids
Recordati Rare Diseases Inc. (Paris, França)
2013/05/30 Ether-phospholipid functions on Schwann cell differentiation and myelination XIII meeting of the Portuguese Society for Neuroscience
Portuguese Society for Neuroscience (Luso, Portugal)
2010/03/28 Refsum disease 2010 European Leukodystrophy Association (ELA) conference
European Leukodystrophy Association (ELA) (Paris, França)
2007/03/30 Biochemistry, genetics and pathology of Refsum disease Pro Retina Research Colloquium
PRO RETINA Germany (Potsdam, Alemanha)
2006/09/18 The contribution of mouse models to the understanding of human peroxisomal disorders Open European Peroxisome Meeting
Katholieke Universiteit Leuven (Leuven, Bélgica)

Orientação

Título / Tema
Papel desempenhado
Curso (Tipo)
Instituição / Organização
2024/01/01 - Atual Understand the impact of impaired S-acylation in neuron biology through the characterization of the Zdhhc14 knockout mouse
Orientador
2022/04/15 - Atual Determine the impact of Slc44a1 deficiency in central nervous system myelination
Orientador
2022/02/18 - Atual Understand how ether-phospholipids dysregulate the synaptogenesis process
Orientador
2021/10/01 - Atual Unraveling the impact of very-long-chain fatty acids on neuron pathology
Orientador
2018/11/01 - Atual Understanding how ACBD5 mediates lipid dysregulation and neuropathology
Orientador
Molecular and Cell Biology (Doutoramento)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2020/09/28 - 2021/11/29 Understand how ether-phospholipids dysregulate neuron processes
Orientador
2018/08/01 - 2020/02/07 Unraveling the role of the fatty acid hydroxylase Faxdc2 in nervous tissue
Orientador
Molecular and Cellular Biology (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
2018/08/01 - 2019/12/11 Unravel the functions of Acbd5 through the generation and characterization of mouse mutants
Orientador
Applied Biochemistry (Mestrado)
Universidade do Minho, Portugal
2013/09/01 - 2019/07/16 "Unraveling the function of ether-phospholipids in CNS and their role in neurodegeneration"
Orientador
Molecular and Cell Biology (Doutoramento)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2013/02/01 - 2017/11/30 "Characterization of plasmalogen´s role during nervous system and muscle development"
Orientador
Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2016/09/01 - 2017/07/15 “Determining how membrane phospholipids regulate CNS myelination and myelin composition”
Orientador
Molecular and Cellular Biology (Mestrado)
Universidade de Aveiro, Portugal
2017/01/01 - 2017/02/01 Characterization of the mechanism mediating the relocation of the axon initial segment
Orientador
Medicina (Licenciatura/Bacharelato)
Universidade de Coimbra Faculdade de Medicina, Portugal
2014/10/01 - 2015/07/27 Characterization of a plasmalogen deficiency in microtubule cytoskleleton dynamics
Orientador
Bioquímica (Licenciatura/Bacharelato)
Universidade do Porto Faculdade de Ciências, Portugal
2011/04/01 - 2012/12/15 "Morphometric analysis of central and peripheral nervous tissues in mice with defects in the biosynthesis of ether-phospholipids”
Orientador
Molecular Therapies (Mestrado)
Instituto Universitário de Ciências da Saúde, Portugal
2011/09/01 - 2012/11/15 “Determination of the role of plasmalogens in nervous tissue and assessment of therapeutic approaches”
Orientador
Biochemistry (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2010/09/01 - 2011/10/15 “Determination of the role of plasmalogens in regeneration and during myelination”
Orientador
Biochemistry (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2009/09/01 - 2010/10/31 “Peroxisome assessment in the peripheral nervous system and the characterization of plasmalogen’s role during muscle development”
Orientador
Biochemistry (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação)
Instituição / Organização
2016/05/16 - Atual Seminar series of the Neurobiology and Neurologic Disorders Integrative Program at i3S (2016/05/12)
Seminário (Coorganizador)
2023/08/02 - 2023/08/04 15th Biennial ISN Satellite Meeting on MYELIN BIOLOGY (2023/08/02 - 2023/08/04)
Simpósio (Coorganizador)
International Society for Neurochemistry, Suiça
2019/07/10 - 2019/07/13 XIV European Meeting on Glial Cells in Health and Disease. (2019/07/10)
Congresso (Membro da Comissão Científica)
2018/11/29 - 2018/11/30 i3S Annual Meeting (2018/11/29 - 2018/11/30)
Encontro (Coorganizador)
2018/09/20 - 2018/09/20 1st Retreat of the Neurobiology and Neurologic Disorders Integrative Program of i3S (2018/09/20 - 2018/09/20)
Encontro (Coorganizador)
2014/10/30 - 2014/10/31 i3S Annual Meeting (2014/10/30 - 2014/10/31)
Encontro (Coorganizador)

Júri de grau académico

Tema
Tipo de participação
Nome do candidato (Tipo de grau)
Instituição / Organização
2021/11/30 Understand how ether-phospholipids dysregulate neuron processes
Orientador
Jaqueline Evelin Zortéa (Mestrado)
2021/10/04 Characterization of neuronal network dynamics on microelectrode arrays: assessing the effect of temperature and the activity profile of long-term recordings;
Arguente principal
João Tiago dos Santos Palma (Mestrado)
2020/12/14 Characterization of Prrxl1-S119A phospho-defective mouse: Impact on the development of nociceptive neurons
Arguente principal
Francisco Tomás Ribeiro (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
2018/07/27 Stargazin as a regulator of neuronal excitability
Arguente principal
Marina Rodrigues (Doutoramento)
Universidade de Coimbra Instituto de Investigação Interdisciplinar, Portugal
2017/07/15 Determining how membrane phospholipids regulate CNS myelination and myelin composition
Orientador
Barbara Gonçalves Correia (Mestrado)
Universidade de Aveiro, Portugal
2012/12/06 Morphometric analysis of central and peripheral nervous tissues in mice with defects in the biosynthesis of ether-phospholipids
Orientador
Ana Rita Malheiro (Mestrado)
Instituto Universitário de Ciências da Saúde, Portugal
2012/11/15 Determination of the role of plasmalogens in nervous tissue and assessment of therapeutic approaches
Orientador
Jessica Faria da Eira (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
2012/01/25 The role of peroxisomes in the formation and maintenance of myelinated axons
Arguente principal
Astrid Bottelbergs (Doutoramento)
Katholieke Universiteit Leuven, Bélgica
2011/10/10 Determination of the role of plasmalogens in regeneration and during myelination
Orientador
André Teixeira Lopes (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
2010/09/15 Peroxisome assessment in the peripheral nervous system and the characterization of plasmalogen’s role during muscle development
Orientador
Tiago Ferreira da Silva (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal

Consultoria / Parecer

Descrição da atividade Instituição / Organização
2023 - Atual Reviewer for the French National Research Agency (ANR) Agence nationale de la recherche, França
2021/03/01 - Atual Reviewer for the National Science Center Poland (NCN) Narodowe Centrum Nauki, Polónia
2019/01/01 - Atual External expert of Marie Sklodowska-Curie Actions Innovative Training Networks Research Executive Agency, Bélgica

European Commission, Bélgica
2018/11/12 - Atual External expert of H2020-WIDESPREAD actions Research Executive Agency, Bélgica

European Commission, Bélgica
2016/10/01 - Atual Vice-Chair of Life Sciences Panel of Horizon 2020 Marie Sklodowska-Curie Actions Research Executive Agency, Bélgica

European Commission, Bélgica
2013/11/08 - Atual External expert of SPDM-Genzyme-Sanofi fellowships and grants Sociedade Portuguesa de Doenças Metabólicas, Portugal

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2011/04/10 - Atual PhD and MSC Program in Neuroscience Nerve regeneration - role of lipids in axon regeneration and myelination (Doutoramento) Universidade do Porto Faculdade de Medicina, Portugal
2010/05/03 - Atual Graduate Program in Areas of Basic and Applied Biology (GABBA) Nerve regeneration - role of lipids in axon regeneration and myelination (Doutoramento) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/09/10 - 2018/09/21 Laboratory Animal Science Course Laboratory Animal Genetics (Outros) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2010/10/18 - 2010/10/22 the Harvard Medical School-Portugal Postgraduate Medical Education Animal models of PNS and CNS injury (Doutoramento)

Tutoria

Tópico Nome do aluno
2017/12/01 - Atual Postdoc supervision Tiago Silva
2017/01/01 - Atual Postdoc supervision Filipa Sofia Franquinho
2018/04/01 - 2019/09/30 Supervision of Research Technicians Barbara Gonçalves Correia
2017/06/01 - 2018/10/31 Supervision of Research Technicians Luis Granadeiro
2017/06/01 - 2018/01/31 Supervision of Research Technicians João Magalhães
2015/03/15 - 2017/07/31 Supervision of Research Technicians Digo Neto
2013/10/01 - 2014/04/30 Postdoc supervision Lorena Rodrigues
2013/01/01 - 2013/12/31 Supervision of Research Technicians Marta Jordão
2011/04/01 - 2013/08/31 Supervision of Research Technicians Ana Rita Malheiro
Distinções

Outra distinção

2020 CEEC-IND award
Fundação para a Ciência e a Tecnologia, Portugal
2013 FCT Investigator award
Fundação para a Ciência e a Tecnologia, Portugal
2011 Postdoc fellowship
European Leukodystrophy Association, França
2009 Postdoc fellowship
Fundação para a Ciência e a Tecnologia, Portugal